Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGE IN STOCKHOLDERS EQUITY

v3.19.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGE IN STOCKHOLDERS EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings / (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2017   27,707,328    
Beginning balance at Dec. 31, 2017 $ 28,526 $ 3 $ 22,968 $ 5,555
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 318   318  
Exercise of RSUs and stock options (in shares)   12,500    
Net income (loss) 29,219     29,219
Accretion of Series A-1 preferred stock (925)   (925)  
Ending balance (in shares) at Mar. 31, 2018   27,719,828    
Ending balance at Mar. 31, 2018 59,688 $ 3 22,361 37,324
Beginning balance (in shares) at Dec. 31, 2018   27,568,656    
Beginning balance at Dec. 31, 2018 54,679 $ 3 28,534 26,142
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 246   246  
Exercise of RSUs and stock options (in shares)   27,184    
Net income (loss) (6,002)     (6,002)
Accretion of Series A-1 preferred stock 0      
Ending balance (in shares) at Mar. 31, 2019   27,595,840    
Ending balance at Mar. 31, 2019 $ 48,923 $ 3 $ 28,780 $ 20,140